13295-53-9

Basic information

• Product Name: Cyclobutylmethyl 4-methylbenzenesulfonate
• Synonyms: Cyclobutylmethyl 4-methylbenzenesulfonate;Toluene-4-sulfonic acid cyclobutylmethyl ester
• CAS NO: 13295-53-9
• Molecular Formula: C₁₂H₁₆O₃S
• Molecular Weight: 240.32
• Mol File: 13295-53-9.mol
• Article Data: 17

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Cyclobutylmethyl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutylmethyl 4-methylbenzenesulfonate(13295-53-9)
• EPA Substance Registry System: Cyclobutylmethyl 4-methylbenzenesulfonate(13295-53-9)

Safety Data

• Hazardous Substances Data: 13295-53-9(Hazardous Substances Data)

Upstream product

• 4415-82-1 cyclobutanemethanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 3721-95-7 Cyclobutanecarboxylic acid 
• 3779-29-1 diethyl cyclobutane-1,1-dicarboxylate 
• 5006-22-4 Cyclobutanecarbonyl chloride 
• 14924-53-9 ethyl cyclobutylcarboxylate 

Downstream Products

• 4426-03-3 cyclobutyl acetonitrile 
• 63659-60-9 4-(2-cyclobutylmethylthio-ethyl)-1-methoxy-benzene 
• 4426-06-6 DL-2-amino-3-cyclobutylpropanoic acid 
• 14034-69-6 Toluene-4-sulfonic acid; compound with 4-methoxy-phenylamine 
• 14034-57-2 anilinium p-tolylsulfonate 
• 104-15-4 toluene-4-sulfonic acid 
• 1275599-80-8 N-(2-(cyclobutylmethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 
• 60637-97-0 2-cyclobutylethan-1-amine 
• 4415-84-3 3-cyclobutylpropionic acid 
• 63659-74-5 1-[4-(2-Cyclobutylmethoxy-ethyl)-phenoxy]-3-[2-(3,4-dimethoxy-phenyl)-ethylamino]-propan-2-ol 
• 108007-85-8 N-(2-{3-[4-(2-Cyclobutylmethoxy-ethyl)-phenoxy]-2-hydroxy-propylamino}-ethyl)-acetamide 
• 69322-26-5 3-{3-[4-(2-Cyclobutylmethoxy-ethyl)-phenoxy]-2-hydroxy-propylamino}-butyronitrile 
• 108007-95-0 1-[4-(3-Cyclobutylmethoxy-propyl)-phenoxy]-3-isopropylamino-propan-2-ol 
• 108007-84-7 1-[4-(2-Cyclobutylmethoxy-ethyl)-phenoxy]-3-cyclopropylamino-propan-2-ol 

Relevant articles and documents

NON-FUSED TRICYCLIC COMPOUNDS

Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.

THIAZOLES AS MODULATORS OF RORyt

The present invention comprises compounds of Formula I. Formula I wherein: R1, R2, R3, R4, R5, R7, R8, and (A) are defined in the specification. The invention also comprises a co

MUSCARINIC AGONISTS

Compounds of formula (I) and methods are provided for the treatment of disease or conditions in which modification of cholinergic, especially muscarinic receptor activity, has a beneficial effect.